Best Blue Chip Stocks this April 2026

UnitedHealth Group (UNH) stands out as a leading blue-chip investment, currently offering a dividend yield of approximately 3.10%. Despite facing challenges with a one-year return of -48.48% and a five-year return of -29.91%, it maintains strong analyst support, earning a consensus Buy rating with a median price target of $390.50. Notably, Berkshire Hathaway recently increased its stake, acquiring over 5 million shares, underscoring confidence in UNH's long-term potential.

UnitedHealth Group (UNH) has a consensus rating of Buy from 24 analysts, with 25% recommending Strong Buy, 54% Buy, 13% Hold, and 8% Sell.

Warren Buffett's Berkshire Hathaway purchased over 5 million shares of UnitedHealth last quarter, valued at approximately $1.6 billion.

Coca-Cola (KO) stands out as a reliable blue-chip investment, offering a dividend yield of 2.66% while consistently appealing to dividend-seeking investors. With a strong track record of consecutive dividend increases, earning it "Dividend King" status, it has delivered a solid 39.54% return over the past five years. Analysts maintain a positive outlook, with a median 12-month price target of $85.00, reflecting strong confidence in its enduring market position.

To earn $1,000 annually in dividends from Coca-Cola, you would need to own approximately 472 shares, given its dividend yield of 2.84%.

In five years, Coca-Cola is expected to maintain its stable operations, appealing to investors seeking reliability in an unpredictable economic environment.

Microsoft (MSFT) is recognized as an undervalued blue-chip stock with a strong competitive advantage, making it an appealing choice for long-term investors. With a modest dividend yield of just under 1%, it has experienced a 1-year return of -8.29%, yet boasts a solid 5-year return of 52.26%. Analysts maintain a positive outlook with a median price target of $600, signaling significant upside potential despite recent volatility.

The all-time high closing price for Microsoft stock was $539.83 on October 28, 2025.

Micron Technology (MU) stands out as a top-rated blue-chip stock, boasting an impressive 294.71% return over the past year and 315.54% over five years. With a modest dividend yield of 0.14%, it remains an attractive option for investors seeking substantial growth from financially healthy companies. Analysts maintain a positive outlook, setting a median 12-month price target of $443, with ratings ranging from "Buy" to "Outperform."

Merck (MRK) stands out as a defensive leader in the pharmaceutical sector, boasting a dividend yield of approximately 2.88%. The stock has shown impressive growth, with a 1-year return of 37.39% and a remarkable 5-year return of 61.20%. Analysts maintain a positive outlook, setting a median 12-month price target of $133.00, reflecting strong potential for continued upside.

Merck may be the better option for dividend seekers, as it has a lower forward dividend yield of 3.4% compared to Pfizer's 6.5%, but has grown its dividends much faster and currently offers a higher dividend per share.

MRK shares have increased by $0.29, or 0.24%, since the last market close, opening at $118.95.

Warren Buffett began investing in Merck in Q3 2020 but sold his entire stake between Q1 2021 and Q3 2021 after offloading 28.7 million shares.

Verizon (VZ) stands out as a top-rated blue-chip dividend stock, offering a compelling yield of 5.45% and a strong buy recommendation from analysts. With a robust 12-month price target range of $44 to $58 and a median target of $49, investors can expect solid performance despite a recent 5-year return of -12.83%. This stock is ideal for those seeking reliable income from financially healthy companies, making it a noteworthy option in today's market.

Warren Buffett has traded shares of Verizon Communications Inc since Q1 2014, but he completely sold his stake between Q1 2022 and Q2 2022.